Rocket Pharmaceuticals appoints R. Keith Woods to Board of Directors

ROCKET PHARMACEUTICALS, INC.

Appointed R. Keith Woods, former COO of argenx SE, to the Board effective December 7, 2023.
Granted options to purchase 20,522 shares (3-year monthly vest) and 11,960 shares (1-year cliff vest).
Woods has 30+ years biopharma experience; previously SVP North American operations at Alexion, managed $1B+ annual sales.
No arrangements or family relationships disclosed; standard indemnification agreement.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

R. Keith Woods

Director

RCKT · ROCKET PHARMACEUTICALS, INC.

Effective: 2023-12-07
Filed: December 13, 2023, 6:59 PM ET

appointed R. Keith Woods to the Board, effective December 7, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

R. Keith Woods was appointed as Director at ROCKET PHARMACEUTICALS, INC..

Action: appointed
Role: Director

Exact text from the filing

appointed R. Keith Woods to the Board, effective December 7, 2023.

View on SEC.gov

ROCKET PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001140361-23-057478

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.